Discover the Divis Labs Stock Liveblog, your ultimate resource for real-time updates and insightful analysis on a prominent ...

Entresto is considered a cornerstone of Divi’s innovator-driven custom synthesis portfolio, contributing close to 40 percent ...

Opportunities in traditional pharma companies with a focus on domestic formulations and US generic drugs are drying up ...

Stay up-to-date with the Divis Labs Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on ...

Brokerage firm IIFL has warned that due to this development, Divi's Laboratories' annual Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) could see a potential decline of 12% to ...

Divi's Labs makes active pharmaceutical ingredients for Entresto for Novartis, which contributes nearly 8% to Hyderabad-based drugmaker's revenue.

Here's an analysis of the annual report of DIVIS LABORATORIES for 2024-25. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the ...

HSBC Global Research has upgraded Divi's Laboratories Ltd. to 'buy' rating, citing promising growth trajectory driven by its involvement in the production of anti-diabetes drug tirzepatide, other ...

As of noon, Divis Laboratories shares were trading at ?6,737, reflecting a 3.95% increase. In contrast, the BSE Sensex saw a milder rise, gaining 0.57% to settle at 82,189.23. Later, the stock ...

Within each site, Divi’s Labs utilizes the EX4600 as Core/Distribution switches, while EX3400 and EX2300 switches provide connectivity to critical network resources including Wi-Fi Access Points.

India's Divi's Laboratories reported a better-than-expected quarterly profit on Monday, aided by strong performance of its business that focuses on customised production of chemical compounds used ...